Development of agonist epitopes of the human papillomavirus
AssigneeThe United States of America, as represented by the Secretary, Department of Health and Human Services
InventorsJeffrey Schlom, Kwong-Yok Tsang
Life of this patent
Estimating the term…
Abstract
The invention provides HPV agonist epitopes, which can be used as a peptide, polypeptide (protein), and/or in a vaccine or other composition for the prevention or therapy of HPV infection and/or cancer. The invention further provides a nucleic acid encoding the peptide or polypeptide (protein), a vector comprising the nucleic acid, a cell comprising the peptide, polypeptide (protein), nucleic acid, or vector, and compositions thereof.
Claims33
A peptide comprising the amino acid sequence of SEQ ID NO:
- 1, SEQ ID NO:
- 2, or SEQ ID NO:
- 3.
(canceled)
A method of inducing an immune response against an HPV-associated cancer in a subject comprising:
- (a) administering to the subject a first vector comprising a nucleic acid encoding the amino acid sequence of SEQ ID NO:
- 1, SEQ ID NO:
- 2, or SEQ ID NO:
- 3 and
- (b) administering to the subject a second vector comprising a nucleic acid encoding the amino acid sequence of SEQ ID NO:
- 1, SEQ ID NO:
- 2, or SEQ ID NO:
- 3.
Dependencies are inferred from the claim text.